Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
585
currently held
Exits tracked
189
hand-checked
Sectors covered
1
across the portfolio
Countries covered
30
from every market
740 companies matching · Page 6 of 15
Arctoris
Future Planet Fund I
Sector
Biotech
InvestorFuture Planet Capital
Entry
2019
Hold
7yr
Argobio
Angelini Ventures
Sector
Biotech
InvestorAngelini Ventures
Entry
2021
Hold
5yr
ArkVax
UK Innovation and Science Seed Fund
Sector
Biotech
InvestorFuture Planet Capital
Entry
2022
Hold
4yr
ArsenalBio
Hitachi Ventures Fund II
Sector
Biotech
InvestorHitachi Ventures
Entry
2022
Hold
4yr
Artax Biopharma
Columbus Innvierte Life Science Fund I
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2020
Hold
6yr
Ascend Advanced Therapies
4BIO Ventures III
Sector
Biotech
Investor4Bio Partners
Entry
2023
Hold
3yr
Ascend Gene & Cell Therapies
Abingworth Bioventures 8
Sector
Biotech
InvestorAbingworth
Entry
2023
Hold
3yr
AstronauTx
Dementia Discovery Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2019
Hold
7yr
Atlas Molecular Pharma
Inveready Biotech III
Sector
Biotech
InvestorInveready Asset Management
Entry
2021
Hold
5yr
Atrandi Biosciences
Vsquared Ventures II
Lithuania
Sector
Biotech
InvestorVsquared Ventures
Entry
2025
Hold
1yr
AudioCure
HTGF II
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2012
Hold
14yr
Aurobac Therapeutics
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2023
Hold
3yr
Auron Therapeutics
Apollo Health Ventures Fund II
Sector
Biotech
InvestorApollo Health Ventures
Entry
2022
Hold
4yr
Avantea
Taste of Italy 2
Sector
Biotech
InvestorDeA Capital Alternative Funds SGR
Entry
2024
Hold
2yr
Awen Oncology
Development Bank of Wales (Balance Sheet)
Sector
Biotech
InvestorDevelopment Bank of Wales
Entry
2024
Hold
2yr
Axovia Therapeutics
ALSA Ventures European Biotechnology Fund
Sector
Biotech
InvestorALSA Ventures
Entry
2023
Hold
3yr
Barinthus Biotherapeutics
Future Planet Fund I
Sector
Biotech
InvestorFuture Planet Capital
Entry
2020
Hold
6yr
Baseimmune
IQ Capital Fund III
Sector
Biotech
InvestorIQ Capital Partners
Entry
2021
Hold
5yr
Batea Oncology, S.L.
SODIGA Galicia
Sector
Biotech
InvestorXesGalicia
Entry
2025
Hold
1yr
BDI Biotech
Inveready Biotech II
Sector
Biotech
InvestorInveready Asset Management
Entry
2017
Hold
9yr
Beacon Therapeutics
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2023
Hold
3yr
Bicycle Therapeutics
CIC Fund I
Sector
Biotech
InvestorCambridge Innovation Capital
Entry
2016
Hold
10yr
Bindbridge
Nucleus Capital II
Sector
Biotech
InvestorNucleus Capital
Entry
2026
Hold
0yr
BioAscent
Maven Income and Growth VCT 4
Sector
Biotech
InvestorMaven Capital Partners
Entry
2018
Hold
8yr
Biocross
ADE Capital Sodical
Sector
Biotech
InvestorSodical
Entry
2011
Hold
15yr
Biomatter
UVC Fund IV
Lithuania
Sector
Biotech
InvestorUnternehmertum Venture Capital Partners
Entry
2024
Hold
2yr
Biomia
Nucleus Capital I
Sector
Biotech
InvestorNucleus Capital
Entry
2023
Hold
3yr
bioXXmed AG
Deutsche Balaton Evergreen Holding (Balance Sheet)
Sector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2024
Hold
2yr
bit.bio
BlueYard Capital Fund II
Sector
Biotech
InvestorBlueYard Capital
Entry
2019
Hold
7yr
Bitrobius Genetics
UK Innovation and Science Seed Fund
Sector
Biotech
InvestorFuture Planet Capital
Entry
2023
Hold
3yr
BiVictriX Therapeutics
Development Bank of Wales (Balance Sheet)
Sector
Biotech
InvestorDevelopment Bank of Wales
Entry
2016
Hold
10yr
Bota Bio
BASF Venture Capital Evergreen Fund
China
Sector
Biotech
InvestorBASF Venture Capital
Entry
2021
Hold
5yr
Bright Biotech
FoodLabs Fund II
Sector
Biotech
InvestorFoodLabs
Entry
2022
Hold
4yr
Bright Peak Therapeutics
TVM Life Science Ventures
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2020
Hold
6yr
Broken String
DvH Ventures Fund IV (Digital Health Fund)
Sector
Biotech
InvestorDvH Ventures
Entry
2021
Hold
5yr
Capricorn Scientific GmbH
Hessen Kapital
Sector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2017
Hold
9yr
CaSRevolution
Utopia SIS
Sector
Biotech
InvestorUtopia SIS
Entry
2023
Hold
3yr
Cebiotex
Inveready Biotech II
Sector
Biotech
InvestorInveready Asset Management
Entry
2016
Hold
10yr
Celea Therapeutics
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2026
Hold
0yr
CellCentric
UK Innovation and Science Seed Fund
Sector
Biotech
InvestorFuture Planet Capital
Entry
–
CellDrive
BeAble Innvierte KETs Fund
Sector
Biotech
InvestorBeAble Capital
Entry
2021
Hold
5yr
Cellino Biotech
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2022
Hold
4yr
Centauri Therapeutics
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2022
Hold
4yr
Cerevance
Dementia Discovery Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2016
Hold
10yr
Change Foods
Green Generation Fund I
Sector
Biotech
InvestorGreen Generation Fund
Entry
2022
Hold
4yr
Cimico
Moira Capital Desarrollo
Sector
Biotech
InvestorMoira Capital Partners
Entry
2023
Hold
3yr
Cleara Biotech
Apollo Health Ventures Fund II
Sector
Biotech
InvestorApollo Health Ventures
Entry
2022
Hold
4yr
clock.bio
BlueYard Capital Fund III
Sector
Biotech
InvestorBlueYard Capital
Entry
2024
Hold
2yr
Cocoon Bioscience
Columbus Life Sciences Fund IV
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2024
Hold
2yr
Code Biotherapeutics
4BIO Ventures III
Sector
Biotech
Investor4Bio Partners
Entry
2022
Hold
4yr